Q2 2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Panlong Pharmaceutical(002864) the Revenue is 200.04 M (-38.22%);the EBIT is 33 M (+52.65%);the EPS is 0.149 (-28.51%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.20B38.22%
----
----
EBIT
0.03B52.65%
----
----
EPS
0.148728.51%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf